HomeCompareMET vs HRC

MET vs HRC: Dividend Comparison 2026

MET yields 3.33% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRC wins by $2.22M in total portfolio value
10 years
MET
MET
● Live price
3.33%
Share price
$68.27
Annual div
$2.27
5Y div CAGR
23%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.3K
Annual income
$4,879.85
Full MET calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — MET vs HRC

📍 HRC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMETHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MET + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MET pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MET
Annual income on $10K today (after 15% tax)
$282.63/yr
After 10yr DRIP, annual income (after tax)
$4,147.87/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, HRC beats the other by $1,205,767.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MET + HRC for your $10,000?

MET: 50%HRC: 50%
100% HRC50/50100% MET
Portfolio after 10yr
$1.15M
Annual income
$714,154.74/yr
Blended yield
62.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MET right now

MET
Analyst Ratings
24
Buy
8
Hold
Consensus: Buy
Price Target
$96.83
+41.8% upside vs current
Range: $90.00 — $101.00
Altman Z
0.1
Piotroski
8/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MET buys
8
HRC buys
0
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$MET▲ Buy$1,001 - $15,0002025-09-29
Ro Khanna🏢 House$MET▼ Sell$1,001 - $15,0002025-08-26
Ro Khanna🏢 House$MET▼ Sell$1,000 - $15,0002025-08-26
Gilbert Cisneros🏢 House$MET▼ Sell$1,001 - $15,0002025-08-06
Ritchie Torres🏢 House$MET▼ Sell$1,001 - $15,0002025-07-11
Ro Khanna🏢 House$MET▲ Buy$1,001 - $15,0002025-06-13
Sheldon Whitehouse🏛 Senate$MET▼ Sell$1,001 - $15,0002024-11-19
Thomas R. Carper🏛 Senate$MET▼ Sell$1,001 - $15,0002024-01-17
Ro Khanna🏢 House$MET▲ Buy$1,001 - $15,0002023-10-31
Sheldon Whitehouse🏛 Senate$MET▼ Sell$1,001 - $15,0002023-09-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMETHRC
Forward yield3.33%11.38%
Annual dividend / share$2.27$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR23%40.3%
Portfolio after 10y$41.3K$2.26M
Annual income after 10y$4,879.85$1,423,429.65
Total dividends collected$18.1K$2.14M
Payment frequencyquarterlyquarterly
SectorFinancialsStock
Analyst consensusBuyHold

Year-by-year: MET vs HRC ($10,000, DRIP)

YearMET PortfolioMET Income/yrHRC PortfolioHRC Income/yrGap
1← crossover$11,109$408.98$12,296$1,595.93$1.2KHRC
2$12,409$522.27$15,730$2,573.05$3.3KHRC
3$13,948$670.62$21,147$4,316.00$7.2KHRC
4$15,791$866.52$30,235$7,608.15$14.4KHRC
5$18,024$1,127.71$46,615$14,263.36$28.6KHRC
6$20,765$1,479.66$78,712$28,834.27$57.9KHRC
7$24,179$1,959.61$148,063$63,841.01$123.9KHRC
8$28,494$2,622.90$315,890$157,462.80$287.4KHRC
9$34,042$3,553.25$778,498$440,495.17$744.5KHRC
10$41,305$4,879.85$2,256,422$1,423,429.65$2.22MHRC

MET vs HRC: Complete Analysis 2026

METFinancials

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Full MET Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this MET vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MET vs SCHDMET vs JEPIMET vs OMET vs KOMET vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.